(RTTNews) - Neuronetics, Inc. (STIM), a neurohealth technology company, on Wednesday announced the publication of two significant peer-reviewed studies in the inaugural issue of the Transcranial ...

The FDA has approved a device that aims to treat depression by sending electric current into a part of the brain known to ...

MALVERN, Pa., Jan. 29, 2025 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for ...

As previously announced, low dose D-cycloserine has been associated with augmentation of the antidepressant and antisuicidal ...

Repetitive transcranial magnetic stimulation (rTMS) and other targeted, noninvasive neuromodulation approaches offer promise for treating neuropsychiatric conditions. These techniques work by ...

Transcranial magnetic stimulation has been a trusted therapy for over four decades, offering hope to those who have not found relief through traditional treatments such as medication or therapy.

Neuronetics announced two publications highlighting the effectiveness of TMS for depression and the superiority of the PHQ-9 assessment tool. Neuronetics, Inc. announced the publication of two ...

Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...

Neuralia TMS believes that this innovative approach to mental health could be a turning point for individuals battling depression. Dr. Shanek Wick, Director of Neuralia TMS, highlights the ...